Why classify leprosy patients into paucibacillary and multibacillary groups?
Reddy, N.B.
Leprosy Review 58(1): 89
1987
ISSN/ISBN: 0305-7518 PMID: 3600151 Accession: 041980626
Full Text Article emailed within 1 workday: $29.90
Related References
Parkash, O. 2009: Classification of leprosy into multibacillary and paucibacillary groups: an analysis Fems Immunology and Medical Microbiology 55(1): 1-5Motta, P.M.ía.F.; Cech, N.; Fontan, C.; Giménez, M.F.; Lodeiro, N.; Marinic, K.; Molinari, M.ía.L.; Sotelo, M.ía.G.; Habegger de Sorrentino, A. 2007: Role of HLA-DR and HLA-DQ alleles in multibacillary leprosy and paucibacillary leprosy in the province of Chaco (Argentina) Enfermedades Infecciosas y Microbiologia Clinica 25(10): 627-631
Jesudasan, K.; Christian, M. 1985: Risk of paucibacillary leprosy patients released from control relapsing with multibacillary leprosy International Journal of Leprosy and other Mycobacterial Diseases: Official Organ of the International Leprosy Association 53(1): 19-21
Takashi, M.D.; Andrade, H.F.; Wakamatsu, A.; Siqueira, S.; De Brito, T. 1991: Interminate leprosy : histopathologic and histochemical predictive parameters involved in its possible change to paucibacillary or multibacillary leprosy International Journal of Leprosy and other Mycobacterial Diseases 59(1): 12-19
Takahashi, M.D.; Andrade, H.F.; Wakamatsu, A.; Siqueira, S.; De Brito, T. 1991: Indeterminate leprosy: histopathologic and histochemical predictive parameters involved in its possible change to paucibacillary or multibacillary leprosy International Journal of Leprosy and other Mycobacterial Diseases: Official Organ of the International Leprosy Association 59(1): 12-19
Van Brakel, W.H.; de Soldenhoff, R.; McDougall, A.C. 1992: The allocation of leprosy patients into paucibacillary and multibacillary groups for multidrug therapy, taking into account the number of body areas affected by skin, or skin and nerve lesions Leprosy Review 63(3): 231-246
Becx-Bleumink, M. 1993: Comment: 'The allocation of leprosy patients into paucibacillary and multibacillary groups for multidrug therapy, taking into account the number of body areas affected by skin, or skin and nerve lesions' Leprosy Review 64(3): 281
Jyothi, P.; Riyaz, N.; Nandakumar, G.; Binitha, M.P. 2008: A study of oxidative stress in paucibacillary and multibacillary leprosy Indian Journal of Dermatology Venereology and Leprology 74(1): 80
Jyothi, P.; Riyaz, N.; Nandakumar, G.; Binitha, M.P. 2007: A study of oxidative stress in paucibacillary and multibacillary leprosy Indian Journal of Dermatology Venereology and Leprology 74(1): 80
Chaurasia, R.N.; Garg, R.K.; Singh, M.K.; Verma, R.; Shukla, R. 2011: Nerve conduction studies in paucibacillary and multibacillary leprosy: a comparative evaluation Indian Journal of Leprosy 83(1): 15-22
Do Sacramento, W.S.; Mazini, P.S.; Franceschi, D.A.S.; de Melo, F.C.; Braga, M.A.; Sell, A.M.; Tsuneto, L.T.; Visentainer, J.E.L. 2012: Frequencies of MICA alleles in patients from southern Brazil with multibacillary and paucibacillary leprosy International Journal of Immunogenetics 39(3): 210-215
Walsh, D.S.; Lane, J.E.; Abalos, R.M.; Myint, K.S.A. 2004: TUNEL and limited immunophenotypic analyses of apoptosis in paucibacillary and multibacillary leprosy lesions Fems Immunology and Medical Microbiology 41(3): 265-269
Morgado de Abreu, M.A.M.; Roselino, A.M.; Enokihara, M.; Nonogaki, S.; Prestes-Carneiro, L.E.; Weckx, L.L.M.; Alchorne, M.M.A. 2014: Mycobacterium leprae is identified in the oral mucosa from paucibacillary and multibacillary leprosy patients Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 20(1): 59-64
Rao, P.N.; Pratap, D.; Ramana Reddy, A.V.; Sujai, S. 2006: Evaluation of leprosy patients with 1 to 5 skin lesions with relevance to their grouping into paucibacillary or multibacillary disease Indian Journal of Dermatology Venereology and Leprology 72(3): 207-210
Mehta, J.; Gandhi, I.S.; Sane, S.B.; Wamburkar, M.N. 1986: Effects of clofazimine and dapsone on rifampicin (Lositril) pharmacokinetics in multibacillary and paucibacillary leprosy cases Symposium on Mutidrug Therapy in Leprosy (1986) 57: 67-76
Soares, D.J.; Neupane, K.; Britton, W.J. 1995: Relapse with multibacillary leprosy caused by rifampicin sensitive organisms following paucibacillary multidrug therapy Leprosy Review 66(3): 210-213
Mehta, J.; Gandhi, I.S.; Sane, S.B.; Wamburkar, M.N. 1986: Effect of clofazimine and dapsone on rifampicin (Lositril) pharmacokinetics in multibacillary and paucibacillary leprosy cases Leprosy Review 57(Suppl 3): 67-76
Mehta, J.; Gandhi, I.S.; Sane, S.B.; Wamburkar, M.N. 1985: Effect of clofazimine and dapsone on rifampicin (Lositril) pharmacokinetics in multibacillary and paucibacillary leprosy cases Indian Journal of Leprosy 57(2): 297-310
Gillis, T.P.; Tan, E.V.; Williams, D.L.; Villahermosa, L.G.; Balagon, M.V.F.; Walsh, G.P. 1993: Detection of Mycobacterium leprae DNA by PCR in skin scrapings and nasal secretions from multibacillary and paucibacillary leprosy patients International Journal of Leprosy and Other Mycobacterial Diseases 61(4 Suppl): 106A
Teixeira, Márcia.Almeida.Galvão.; Silveira, V.Magalhães.da.; França, E.Rodrigues.de. 2010: Characteristics of leprosy reactions in paucibacillary and multibacillary individuals attended at two reference centers in Recife, Pernambuco Revista da Sociedade Brasileira de Medicina Tropical 43(3): 287-292